Navigation Links
Micromet, Inc. Reports Second Quarter 2008 Financial Results
Date:8/7/2008

BETHESDA, Md., Aug. 7 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company focusing on the development of novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced its financial results for the second quarter and six months ended June 30, 2008.

Summary of Recent Events:

In June, Micromet and MedImmune presented a clinical update for the BiTE(R) antibody blinatumomab (MT103/MEDI-538) at the International Conference on Malignant Lymphoma in Lugano, Switzerland. All seven patients with relapsed non-Hodgkin's lymphoma treated with blinatumomab at the highest dose level presented at the conference responded to the treatment with partial or complete responses. Responses also appeared to be durable. The most frequent side effects observed so far were lymphopenia, pyrexia and leukopenia. Less common adverse events included transient neutropenia and thrombocytopenia, transient increase of liver enzymes and central nervous system events, all of which were fully reversible. In addition, Micromet and MedImmune commenced treatment of patients with acute lymphoblastic leukemia in a phase 2 clinical trial of blinatumomab.

Also in June, Micromet received a milestone payment of $775,000 from Nycomed in connection with the initiation of formal preclinical safety studies for antibody MT203, which has potential applications in the treatment of inflammatory and autoimmune diseases.

In April, Micromet announced the initiation of the first phase 1 clinical trial with its BiTE antibody MT110. The study will explore the safety, pharmacokinetics, pharmacodynamics and anti-tumor activity of MT110 in patients with lung cancer and patients with gastrointestinal cancer. MT110 targets the epithelial cell adhesion molecule (EpCAM or CD326), which is highly expressed on colon, lung, breast, prostate, ovarian, gastric and pancreatic cancer cells and on cancer stem cells of colon,
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Micromet, Inc. Reports First Quarter 2008 Financial Results
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. Haemacure Reports Third Quarter 2007 Results
4. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
5. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
6. MDS Reports Third Quarter 2007 Results
7. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
8. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
9. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
10. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
11. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... June 17, 2013 Nearly 26 million ... many as 79 million adults are estimated to have ... prevent type 2 diabetes through weight loss and lifestyle ... help bring your blood sugar level back within the ... factors, 101 Medical Weight Loss physicians can help tailor ...
(Date:6/17/2013)... NY (PRWEB) June 17, 2013 ... & Murphy, LLP are pleased to announce that ... and David L. Scher ( http://www.blockotoole.com/Attorneys/David-L-Scher.shtml ) will ... Z100 (100.3 FM) this Sunday, June 23, 2013 ... will be guests on Kevin Burke's "Get Active" ...
(Date:6/17/2013)... 17, 2013 The producers of Impact ... series of reports highlighting how sustainable farming techniques are ... populations and their demand on food supplies. , ... television series airing in markets around the country on ... Martin Sheen, who is marking the start of his ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 Dallas-based physician ... the nation to offer the hybrid concierge model from ... model to offer her patients a wider variety of ... and a greater emphasis on prevention and wellness had ... who want a concierge-style of medicine, but doesn't force ...
(Date:6/17/2013)... Stem Cell Institute (HSCI) researchers have identified in the ... regulate embryonic stem cell self-renewal, beginning a creative search ... The gene, SALL4, gives stem cells their ability to ... cells. Typically, cells only express SALL4 during embryonic development, ... of acute myeloid leukemia and 10 to 30 percent ...
Breaking Medicine News(10 mins):Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 2Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 4Health News:Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital 2Health News:Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians 2Health News:Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians 3Health News:A new target for cancer drug development 2
... its determination to gear up to meet the avian flu ... keep a close watch on bird flu cases and also ... M A Hakeem said "Though we have no cases of ... measures and the committee to be formed will include representatives ...
... a high childhood IQ irrespective of income and social position. ... and Laura Kubzansky, Harvard's School of Public Health who reported ... ,Childhood IQ of more than 163 score is very ... with a score more than 130 are considered gifted and ...
... cancers are mainly caused by cigarette smoking and smoking ... occurrence. In order to reduce the risk of cigarette ... of testing //their new range of “safer cigarette” which ... ,The company is testing their new ...
... practical and cost effective new way to combat the HIV ... modified bacteria living in the human body to produce chemicals ... occurs on the surfaces of the gut and reproductive areas, ... ,The researchers have successfully modified one of these bacteria ...
... age-related macular degeneration and the genetic mechanisms underlying the ... identification of a bacterium //called Chlamydia pneumoniae in the ... notable that the microorganism is associated with chronic inflammation ... in the diseased eye tissue of five of nine ...
... of bird flu in the famous Ranganathittu bird sanctuary ... Department today said that it was totally geared up ... ,The Department has taken precautionary measures against bird flu ... several countries including Central and Northern China, Russia, Mongolia, ...
Cached Medicine News:Health News:Avian Influenza: Government to set up expert committee 2Health News:Genetically modified bacteria to combat HIV 2Health News:Bird flu threat ruled out: Karnataka Forest Department, 2
(Date:6/17/2013)... 17, 2013 /PRNewswire-iReach/ -- MicroTechnologies recently was awarded a significant ... devices at its Costa Rica facility. ... new Life Science division and will serve to greatly advance ... a major step forward, both for our company and ... remain confidential) has put their faith in the country and ...
(Date:6/17/2013)... June 17, 2013 Sanofi Pasteur, the vaccines ... SNY ), announced today the launch of Headfirst! ... help expand understanding of head lice infestation and how ... first time or managing a recurrent or persistent infestation ... Top experts in the fields of parenting, education and ...
(Date:6/17/2013)... DIEGO, Calif. , June 17, 2013 /PRNewswire/ ... today announced it has completed the acquisition of ... innovations from the compounding pharmacy operations of ... acquisition allows Imprimis to pursue the commercial development ... with a right of first refusal on additional ...
Breaking Medicine Technology:MicroTechnologies Announces Award of Medical Device Contract Manufacturing Line 2Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 2Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 3Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 4Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 5Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative 6Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 2Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 3Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 4Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 5
... YORK , Aug. 2 Reportlinker.com announces that a new market research report is ... Hepatitis C Therapeutics ... http://www.reportlinker.com/p0236386/Hepatitis-C-Therapeutics-Market---Taiwan.html , ... This research service aims to provide an update on ...
... SHANGHAI , Aug. 2 /PRNewswire-Asia/ -- WuXi ... a leading research and development outsourcing company serving the,pharmaceutical, ... the United States , today announced its financial ... . , (Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO ...
Cached Medicine Technology:Hepatitis C Therapeutics Market - Taiwan 2Hepatitis C Therapeutics Market - Taiwan 3Hepatitis C Therapeutics Market - Taiwan 4Hepatitis C Therapeutics Market - Taiwan 5WuXi PharmaTech Announces Second-Quarter 2010 Results 2WuXi PharmaTech Announces Second-Quarter 2010 Results 3WuXi PharmaTech Announces Second-Quarter 2010 Results 4WuXi PharmaTech Announces Second-Quarter 2010 Results 5WuXi PharmaTech Announces Second-Quarter 2010 Results 6WuXi PharmaTech Announces Second-Quarter 2010 Results 7WuXi PharmaTech Announces Second-Quarter 2010 Results 8WuXi PharmaTech Announces Second-Quarter 2010 Results 9WuXi PharmaTech Announces Second-Quarter 2010 Results 10WuXi PharmaTech Announces Second-Quarter 2010 Results 11WuXi PharmaTech Announces Second-Quarter 2010 Results 12WuXi PharmaTech Announces Second-Quarter 2010 Results 13WuXi PharmaTech Announces Second-Quarter 2010 Results 14WuXi PharmaTech Announces Second-Quarter 2010 Results 15WuXi PharmaTech Announces Second-Quarter 2010 Results 16
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: